Healthtech startup Sunfox Technologies raised Rs 15 Cr from Venture Catalysts
Sunfox Technologies, a health-tech startup, has raised Rs 15 crore in a pre-Series A funding round led by Venture Catalysts. Finvolve, through the IA Growth Opportunities Fund I and Brew Opportunities Fund, as well as Universal Group, RP Singhvi Group, and other investors, also participated.
Through SAMRIDH Health and LetsVenture, the company had previously raised an investment of Rs 5 crore from USAID. Shark Tank India also featured it. Sunfox said in a press release that the additional funding will be used for growth in India and around the world, with a particular emphasis on scaling its flagship product, Spandan.
Sunfox is an R&D lab that was co-founded in 2016 by Rajat Jain, Arpit Jain, Saurabh Badola, Nitin Chandola, and Sabit Rawat. Its goal is to create innovative healthcare technologies for the digital age. With its flagship product, Spandan, users can detect heart attacks and track cardiac health in real time thanks to its smartphone-based portable ECG device that provides clinically accurate 12-lead ECG readings.
According to the Dehradun-based company, Spandan has been used by more than 30,000 people in 20 countries and has helped save over 10,000 lives by identifying cardiac problems early. This technology is proving to be crucial as heart attacks in India are on the rise following the COVID-19 pandemic.
Prestigious universities like Oxford and Wharton have taken notice of Sunfox, which has set up a cutting-edge internal research and development and production facility in Dehradun.
